PI
Amsterdam institute for Immunology and Infectious diseases
-
PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironment
King, L. A., Veth, M., Roos, M., Scheffer, G. L., Popovic, M. A., de Gruijl, T. D. & van der Vliet, H. J., 29 Oct 2025, In: J. Immunother. Cancer. 13, 10, e012255.Research output: Contribution to journal › Article › Academic › peer-review
-
Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy – a feasibility trial
Ubink, A., ten Tusscher, M. R., van der Vliet, H. J., Douma, J. A. J., de Gruijl, T. D., Bontkes, H., Bonnet, P., van Ens, D., Hobo, W., Dolstra, H., Barbé, E., van der Velde, S., Menke-van der Houven van Oordt, C. W., Havenith, S. H. C., Conijn-Mensink, A., van Zweeden, A. A., Westdorp, H., Jacobs, J. F. M. & Buffart, L. M., 1 Jul 2025, In: Brain, Behavior, and Immunity - Health. 46, 101021.Research output: Contribution to journal › Article › Academic › peer-review
-
Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort
van Zweeden, A. A., van der Geest, L. G. M., Pijnappel, E. N., de Vos-Geelen, J., van Hooft, J. E., Stommel, M. W. J., de Wit, G. F., Verheul, H. M. W., van Laarhoven, H. W. M. & the Dutch Pancreatic Cancer Group, May 2025, In: Pancreatology. 25, 3, p. 433-439 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications